Acquired resistance to immunotherapy and future challenges
Nicholas P Restifo, Mark J Smyth, Alexandra Snyder, Nicholas P Restifo, Mark J Smyth, Alexandra Snyder
Abstract
Advances in immunotherapy have resulted in remarkable clinical responses in some patients. However, one of the biggest challenges in cancer therapeutics is the development of resistant disease and disease progression on or after therapy. Given that many patients have now received various types of immunotherapy, we asked three scientists to give their views on the current evidence for whether acquired resistance to immunotherapy exists in patients and the future challenges posed by immunotherapy.
Conflict of interest statement
Competing interests statement
The authors declare competing interests: see Web version for details.
Source: PubMed